| Amanda Lake Faulkner, RN | |
|
21516 Highway 36, Abita Springs, LA 70420-3906 | |
| (225) 321-2128 | |
| Not Available |
| Full Name | Amanda Lake Faulkner |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 21516 Highway 36, Abita Springs, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215411079 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 151652 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Lake Faulkner, RN 21516 Highway 36, Abita Springs, LA 70420-3906 Ph: (225) 321-2128 | Amanda Lake Faulkner, RN 21516 Highway 36, Abita Springs, LA 70420-3906 Ph: (225) 321-2128 |
News Archive
New research from Rhode Island Hospital found that reduced levels of brain-derived neurotrophic factor (BDNF), a protein in the brain that encourages growth of neurons, may be a trait marker for individuals with psychogenic non-epileptic seizures (PNES) (seizures that are psychological in origin). The findings are published in the October 4, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
With all of the stresses of today's modern world, depression is unfortunately becoming a common household word for many people in this country and abroad. During the cold winter months, many also struggle with seasonal depression or "winter blues," known as Seasonal Affective Disorder (SAD). Depression can be caused by any number of factors, such as chronic stress, inactivity, hormone or neurotransmitter imbalances, nutritional deficiencies, medication side effects, chronic inflammation, or lack of adequate sunshine exposure, among others.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Medical Compression Systems, Inc. (MCS), today announced new data further validating the use of the ActiveCare DVT prophylaxis compression system following total joint replacement procedures.
› Verified 2 days ago
Kim C Hymel, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 72079 Maple St, Abita Springs, LA 70420 Phone: 985-892-2070 | |
Whitney Nicholson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 72240 Dogwood Rd, Abita Springs, LA 70420 Phone: 985-807-8148 | |
Mrs. Kristin Leonie Mayer Couch, Registered Nurse Medicare: Medicare Enrolled Practice Location: 25010 Burvant Street, Abita Springs, LA 70420 Phone: 504-339-7175 | |
Mrs. Danielle Chiasson Fitzpatrick, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 22410 Level St, Abita Springs, LA 70420 Phone: 985-273-3692 |